Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-28 00:53:50 - browse：52

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Microbiome research is starting to find links to chronic diseases

Delta passengers in Vegas fall sick while waiting on flight in triple

Hormonal contraceptives don’t actually treat endometriosis

How a Boston hospital is priming medical residents to use GPT

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stanford president’s abrupt resignation sparks debate

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Thermo Fisher plant for manufacturing gene therapies to expand

DIEP, the 'gold standard' of breast reconstruction, is under threat

Emergency workers more likely to restrain Black patients: study

What does generative AI mean for health care? We asked experts

Are infertility treatments 'essential' during the Covid

BioMarin wins approval for gene therapy to treat hemophilia A

Medical student insurance fails on mental health care coverage

hotspot

A new ‘biological computer' targets cancer while sparing healthy cells

A new ‘biological computer' targets cancer while sparing healthy cells

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Microbiome research is starting to find links to chronic diseases

FDA panel to weigh approval of NurOwn, controversial ALS drug

Experts study whether long Covid risk adds up with each reinfection

leisure time

Wikipedia

hotspot

leisure time